Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta
YWHAZproteinYWHAZ (14-3-3-zeta) is a cardioprotective adaptor protein whose downregulation in acute MI reflects early cardiomyocyte injury and ischemic stress.
Pathway placement
Cascade stepMyocardial injury (shared endpoint)
Confidencehigh
RationaleEarly AMI injury marker; downregulated in STEMI; cardioprotection target.
Also acts inPlatelet activation, Endothelial activation/erosion
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableNo
EnsemblENSG00000164924
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(4)
- Plasma Exosomal Proteomics Identifies Differentially Expressed Proteins as Biomarkers for Acute Myocardial Infarction.Biomolecules · 2025 · PMID 40305362 · doi
- Discovery of 14-3-3 zeta as a potential biomarker for cardiac hypertrophy.BMB reports · 2023 · PMID 36977605 · doi
- Serum proteomic analysis reveals the cardioprotective effects of Shexiang Baoxin Pill and Suxiao Jiuxin Pill in a rat model of acute myocardial infarction.Journal of ethnopharmacology · 2022 · PMID 35405256 · doi
- Proteomic analysis revealed the pharmacological mechanism of Xueshuantong injection in preventing early acute myocardial infarction injury.Frontiers in pharmacology · 2022 · PMID 36618918 · doi